(Q36757158)

English

Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects

scientific article published on November 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Randomized comparison of cefepime and ceftazidime for treatment of skin, surgical wound, and complicated urinary tract infections in hospitalized subjects (English)

1 reference

Europe PubMed Central

16 August 2017

urinary tract infection

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1128/AAC.35.11.2371

https://api.crossref.org/works/10.1128/AAC.35.11.2371

29 November 2022

author name string

L. O. Gentry

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1804010

29 November 2022

G. Rodriguez-Gomez

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1804010

29 November 2022

language of work or name

0 references

publication date

1 November 1991

1 reference

Europe PubMed Central

16 August 2017

full work available at URL

https://europepmc.org/articles/PMC245387

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1804010

29 November 2022

https://europepmc.org/articles/PMC245387?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1804010

29 November 2022

https://journals.asm.org/doi/pdf/10.1128/AAC.35.11.2371

1 reference

10.1128/AAC.35.11.2371

https://api.crossref.org/works/10.1128/AAC.35.11.2371

29 November 2022

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

16 August 2017

35

1 reference

Europe PubMed Central

16 August 2017

2371-2374

1 reference

Europe PubMed Central

16 August 2017

11

1 reference

Europe PubMed Central

16 August 2017

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245387

29 September 2017

In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245387

29 September 2017

In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245387

29 September 2017

Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245387

29 September 2017

Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245387

29 September 2017

The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=245387

28 June 2018

In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1804010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates

1 reference

https://pubmed.ncbi.nlm.nih.gov/1804010

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.35.11.2371

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36757158&oldid=1782520256"